Home About us Contact
|
Home About us Contact | ||
|
|
||
DNA/drug Complexes (drug + complex)
Selected AbstractsPositive ion electrospray ionization mass spectrometry of double-stranded DNA/drug complexesRAPID COMMUNICATIONS IN MASS SPECTROMETRY, Issue 24 2001Rajesh Gupta An Erratum has been published for this article in Rapid Communicatons in Mass Spectrometry 16(7) 2002,740,741. Positive ion electrospray ionization mass spectra of 16 base-pair double-stranded (ds)DNA have been obtained with essentially no ions from single-stranded DNA present. Single-stranded DNA was minimized by: (1) careful choice of DNA sequences; (2) the use of a relatively high salt concentration (0.1,M ammonium acetate, pH 8.5), and, (3) a low desolvation temperature (40,°C). Similarly, ESI-MS complexes of dsDNA with cisplatin, daunomycin and distamycin were obtained that contained only negligible amounts of single-stranded DNA. The complexes with daunomycin and distamycin were more stable to strand separation in the gas phase than dsDNA alone. This is in agreement with solution studies and with other recent gas phase results. These data contrast with many earlier ESI-MS studies of dsDNA and DNA/drug complexes in which ions from ssDNA are also normally observed. Copyright © 2001 John Wiley & Sons, Ltd. [source] Order-disorder enantiotropy, monotropy, and isostructurality in a tetroxoprim-sulfametrole 1:1 molecular complex: Crystallographic and thermal studiesJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 11 2003Mino R. Caira Abstract Two enantiotropic polymorphs of a tetroxoprim (TXP)-sulfametrole (SMTR) 1:1 molecular complex monohydrate and two isostructural TXP-SMTR 1:1 molecular complex solvates with methanol and ethanol were grown and studied by X-ray diffraction and thermal methods (thermogravimetric analysis and differential scanning calorimetry). Interconversion of the polymorphic hydrates is essentially an order/disorder transition involving a substituent on the TXP molecule. These hydrated phases may be described as "nearly isostructural" with the methanol and ethanol solvates. Thermal data for decomposition of the solvates were rationalized on the basis of the location and topologies of solvent crystallographic sites. Solid-state properties of two monotropic polymorphs of the unsolvated TXP-SMTR 1:1 molecular complex were also investigated and the theoretical and experimental phase diagrams of the individual components were assessed. The existence of polymorphic and pseudopolymorphic forms is determined by conformational flexibility of the TXP-SMTR bimolecular complex components, a tendency for molecular disorder in TXP, the ability of the drug complex to form intricate, highly stabilized hydrogen-bonded frameworks, and the competition between nonspecific van der Waals and specific hydrogen bond interactions. © 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2164,2176, 2003 [source] Crystallization and preliminary X-ray diffraction studies of d(ACGTAGCTACGT)2:[actinomycin D, (echinomycin)2] and d(ACGTAGCTACGT)2:[actinomycin D, (triostin A)2] complexesACTA CRYSTALLOGRAPHICA SECTION D, Issue 3 2000Hana L. Takusagawa A DNA,multiple drug complex, d(ACGTAGCTACGT)2:[actinomycin D, (echinomycin)2] has been crystallized. The crystals belong to the monoclinic space group C2, with unit-cell parameters a = 85.6, b = 72.8, c = 56.6,Å, , = 101.5° at 93,K and Z = 8.,The crystal diffracted to 3.0,Å resolution along the DNA fiber axis and to 3.5,Å resolution in other directions. The Patterson maps indicate that all complexes in the crystal are oriented along their helical axes in the [10] direction. [source] Preparation of budesonide/,-cyclodextrin complexes in supercritical fluids with a novel SEDS methodJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 10 2006Tarja Toropainen Abstract The aim was to investigate if solid drug/cyclodextrin complexes could be produced in a single-step process with a solution enhanced dispersion by supercritical fluids (SEDS) method. Budesonide and ,-cyclodextrin (CD) solutions (50% or 99.5% ethanol) were pumped from the same (conventional method) or separate (modified method) containers together with supercritical carbon dioxide through a coaxial nozzle into a particle formation chamber. The pressure was maintained at 100, 150 or 200 bar with a temperature of 40, 60 or 80°C. SEDS-processed powders were characterised with HPLC, DSC and XRPD for budesonide content, complexation and crystallinity. The budesonide dissolution rate was determined in 1% ,-CD aqueous solution. Solid, white budesonide/,-CD complex particles were formed using the conventional and modified SEDS processes. The complexation efficiency was dependent on the processing conditions. For example, with the conventional method (100 bar, 60°C) the yield of the powder was 65,±,12% with 0.14,±,0.02 mg budesonide/mg powder, corresponding to 1:2 drug:CD molar ratio. The dissolution rate of this complexed budesonide (93,±,2% after 15 min) was markedly higher compared to unprocessed micronised budesonide (41,±,10%) and SEDS-processed budesonide without CD (61,±,3%). As a conclusion, SEDS is a novel method to produce solid drug/CD complexes in a single-step process. © 2006 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 95:2235,2245, 2006 [source] Self-association and cyclodextrin solubilization of drugsJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 11 2002Thorsteinn Loftsson Abstract Phase-solubility diagrams are frequently used to calculate stoichiometry of drug/cyclodextrin complexes. Linear diagrams (AL -type systems) are thought to indicate that the complexes are first order with respect to cyclodextrin and first or higher order with respect to the drug. Positive deviation from linearity (AP -type systems) are thought to indicate formation of complexes that are first order with respect to the drug but second or higher order with respect to cyclodextrin. The phase solubility of several different compounds, i.e., cholesterol, ibuprofen, diflunisal, alprazolam, 17,-estradiol and diethylstilbestrol, and various charged and uncharged cyclodextrins was investigated. Phase-solubility diagrams of cholesterol in aqueous cyclodextrin solutions were all of AP type. However, the phase-solubility diagrams obtained with charged cyclodextrins could not be fitted to complexes of second or higher order with respect to cyclodextrin. The phase-solubility diagrams of ibuprofen and diflunisal were of AL type with slope greater than unity indicating formation of 2:1 drug/cyclodextrin complexes. However, Job's plots and space filling docking studies indicated that 1:1 complexes were formed. These and other observations show that stoichiometry of drug/cyclodextrin complexes cannot be derived from simple phase-solubility studies. Furthermore, the results indicate that drug/cyclodextrin complexes can self-associate to form water-soluble aggregates, which then can further solubilize the drug through non-inclusion complexation. © 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2307,2316, 2002 [source] A Within-Group Design of Nontreatment Seeking 5-HTTLPR Genotyped Alcohol-Dependent Subjects Receiving Ondansetron and SertralineALCOHOLISM, Issue 2 2009George A. Kenna Background:, Serotonergic mechanisms are associated with the development of alcohol dependence (AD), however, studies evaluating serotonergic medications have produced conflicting results. One hypothesis suggests that differential response may be due to a functional polymorphism of the 5-HTTLPR promoter region of the serotonin re-uptake transporter (5-HTT). The L/L genotype is postulated to be associated with early onset alcoholism and the S/S or S/L genotypes associated with late onset alcoholism. The aim of this study was to match and mismatch L/L, S/S, or S/L genotypes with administration of ondansetron and sertraline. Methods:, Fifteen nontreatment seeking alcohol-dependent individuals were randomized to 1 of 2 counterbalanced arms to receive either 200 mg/d of sertraline or ondansetron 0.5 mg/d for 3 weeks followed by an alcohol self-administration experiment (ASAE), then received placebo for 3 weeks followed by a second ASAE. Participants then received the alternate drug for 2 weeks followed by a third ASAE. Results:, At the first ASAE compared to sertraline, ondansetron significantly improved drinking outcomes for the L/L genotype for the ASAE volume consumed (100% reduction based on between-subjects comparison, t = 2.35), and for drinks per drinking day during the 7 days prior to the ASAE (79% reduction and t = 4.34). Compared with ondansetron for S/S or S/L genotypes, outcomes at ASAE 1 for sertraline and S/S or S/L genotypes are opposite than hypothesized. Overall, subjects reduced drinking across their participation in the trial, as there appears to be an order effect. Conclusion:, This study suggests that ondansetron may reduce alcohol consumption in alcohol-dependent individuals who have the L/L genotype as measured naturalistically and during the ASAE. By contrast there was no support that sertraline reduces alcohol use in individuals who have S/S or S/L genotypes. Evidence in the literature suggests that AD in some individuals may be influenced by a gene by socio-environmental interaction making pharmacological treatment with serotonergic drugs complex. Research must consider that typologies may predict successful treatment of AD in future trials. [source] Binding and release studies of a cationic drug from a star-shaped four-arm poly(ethylene oxide)- b -poly(methacrylic acid)JOURNAL OF PHARMACEUTICAL SCIENCES, Issue 2 2010E. He Abstract Star-shape polymers possess higher densities of terminal functional groups and three-dimensional tetrahedron structure that induce significantly different association and interactions with drug compared to linear structure of identical molecular weights. Four-arm poly(ethylene oxide)- b -poly(methacrylic acid) block copolymer was synthesized by atom transfer radical polymerization technique, and it self-assembled into core-shell micelles and extended unimers at low and high pH respectively. The negatively charged carboxylate groups on the polymer chains interacted with a cationic drug through electrostatic interaction forming polymer/drug complexes stabilized by biocompatible hydrophilic PEO segments. The hydrodynamic radius (Rh) of the polymeric aggregates and polymer/drug complexes ranged from 46 to 84,nm and 32 to 55,nm at pH of 4.6 and 8.0 respectively, making them suitable for drug delivery applications. The thermodynamic parameters and interactions between polymer and drug were determined by isothermal titration calorimetric technique. The electrostatic force, hydrogen bonding and hydrophobic interactions controlled the characteristics of polymer/drug formation and complexes when the molar ratios of drug and polymer were varied. Drug selective electrode system was used to measure the dynamic release of imipramine hydrochloride (IPH) from multi-arm PEO- b -PMAA star polymer. The release exponent n was greater than 0.5 indicating a non-Fickian type diffusion behavior, where the release behavior was dominated by chain relaxation induced by ion exchange that was dependent on pH. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:782,793, 2010 [source] | ||||||||||